Clinical Trial Update: Prophylactic Entecavir for HBV Reactivation in Past HBV Infected Patients With Hematopoietic Stem Cell Transplantation [NA]

View source ↗

Summary

Enrollment by invitation is ongoing for prophylactic entecavir to prevent hepatitis B reactivation in patients with past HBV infection undergoing hematopoietic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Baraclude (entecavir)

Snippet

Sponsor: Seoul St. Mary's Hospital | Conditions: Hepatitis B Reactivation, Hematopoietic Stem Cell Transplantation | NA | Status: ENROLLING_BY_INVITATION